International CPD Conference
The Canadian Psychiatric Association (CPA) International Continuing Professional Development (ICPD) conference, now in its 24th year, is an event for busy psychiatrists and other health care professionals who want to combine vacation time with the opportunity to earn CPD credits.
The conference will be held Mar. 17-28, 2025 on the Celebrity Beyond out of Fort Lauderdale, which will include stops in the southern Caribbean and Panama. Ports of call include Cartagena, Colombia; Colon, Panama; Kralendijk, Bonaire; Oranjestad, Aruba; and George Town, Grand Cayman. Up to 18 hours of CPD will be available for participants.
Faculty
Raymond W. Lam, MD, FRCPC, FCAHS Dr. Raymond Lam is professor and BC Leadership Chair in Depression Research in the faculty of medicine, University of British Columbia (UBC) and associate head for graduate and undergraduate education for the UBC department of psychiatry. Dr. Lam is also co-director of the Mood Disorders Centre at the Djavad Mowafaghian Centre for Brain Health in Vancouver.
His research examines clinical and biological factors in seasonal, treatment-resistant and workplace depression, biomarkers, clinical trials and guidelines, digital technologies, and global mental health. Dr. Lam is also a lead investigator for the Canadian Biomarker Integration Network in Depression (CAN-BIND), Executive Chair of the Asia-Pacific Economic Cooperation (APEC) Digital Hub for Mental Health hosted at UBC, and Past Executive Chair of the Canadian Network for Mood and Anxiety Treatments (CANMAT). His research is supported by many sponsors including the Canadian Institutes of Health Research.
Dr. Lam has received many awards for his research and teaching. He is a Distinguished Fellow of both the Canadian Psychiatric Association and American Psychiatric Association, and a Foundation Fellow of the International Society for Affective Disorders. In 2020, Dr. Lam was elected as a Fellow of the Canadian Academy of Health Sciences (CAHS), one of the highest honours for individuals in the Canadian health sciences community.
Margaret Ann (Peggy) Richter, MD, FRCPC
Dr. Peggy Richter is the inaugural head and co-lead of the Frederick W. Thompson Anxiety Disorders Centre, director of the clinic for obsessive-compulsive disorder (OCD) and related disorders at Sunnybrook Health Sciences Centre, and head of the sole residential treatment program for severe OCD in Canada. She is professor of psychiatry at the Temerty Faculty of Medicine, University of Toronto, and associate scientist at the Sunnybrook Research Institute. Dr. Richter is internationally known for her work in OCD, focusing on exploration of the genetic and biological basis of this illness, novel treatments and improving outcomes. Funding sources include the Canadian Institutes of Health Research, National Institute of Mental Health and the International Obsessive Compulsive Disorder Foundation.
Dr. Richter is the author of numerous publications and sits on the boards of several advocacy groups, including the scientific advisory board and the Perinatal Task Force of the International OCD Foundation, as well as the scientific boards of Anxiety Canada and the Canadian Body-Focused Repetitive Behaviour (BFRB) Support Network. She co-chaired the development of Ontario Quality Standards for management of OCD and anxiety disorders. She is an internationally acclaimed speaker on anxiety, presenting extensively to both health care professionals and lay audiences. Dr. Richter is passionate about improving understanding and treatment of OCD and the related disorders.
Conference Learning Objectives
By the end of this conference, participants should be able to:
- Improve their management of bipolar disorder, anxiety disorder and obsessive-compulsive disorder and consider the evidence for treatment options
- Personalize treatment options based on the clinical presentations of individual patients with treatment-resistant depression
- Adopt an evidence-based approach to the identification and treatment of mood, anxiety, and related disorders in pregnancy and postpartum
- Consider the role of biomarkers and pharmacogenetics testing for depression
Session Topics Include:
- Cognitive behaviour therapy for obsessive-compulsive disorder (OCD) and anxiety disorders
- Recognition and diagnosis of OCD and anxiety disorders
- The role of medication and neuromodulation in management of OCD
- Pharmacological management of anxiety disorders
- Practical implementation of measurement-based care for depression
- Biomarkers and pharmacogenetics testing for depression
- Latest guidelines updates for treatment-resistant depression, perinatal mood disorders and bipolar disorders
- Biomarkers and pharmacogenetics testing for depression
Conference Tuition
- CPA members in good standing: $1,495 plus applicable taxes
- Non-members: $1,695
If you are not a CPA member yet, consider joining at https://www.cpa-apc.org/application/
Cruise, port fees and airfare are not included.
